All News

The SPRINT trial was the first to demonstrate the benefit of further reduction in blood pressure, but it included a limited Asian population and excluded patients with diabetes or history of stroke.

The SELECT trial expands on existing literature that have shown safety and cardiovascular benefit in individuals with diabetes to now also show benefit in obesity.

Bupivacaine liposome injectable suspension was shown to reduce opioid use after surgery and significantly improve pain.

Throat indications contribute to high antibiotic overprescribing rates.

Specifying a day of the week to take the medication could help avoid inadvertent daily dosing

Tune in to this episode of Pharmacy Focus: Policy Edition for an update on the ever-evolving landscape of pharmacy reimbursements, pharmacy benefit manager reform, and direct and indirect remuneration fees.

The American Heart Association published a statement describing the cardiovascular-kidney-metabolic (CKM) construct, specifically highlighting treatment challenges for CKM syndrome.

Experts discuss challenges and recommendations for addressing diversity, equity, and inclusion in pharmacy programs for minority students.

Jordan Sloshower, MD, MSc, describes his experience working in several clinical trials investigating psilocybin-assisted therapy.

The on-demand enzyme replacement therapy reduced acute thrombotic thrombocytopenic purpura events in patients who experience potentially fatal blood clotting.

The study findings provide the first in-depth look at the relationship between chromosomal changes in tumor cells and immune components of the tumor microenvironment.

Health policies to adapt to climate change must be altered to protect individuals with respiratory diseases in the warmer season.

The sBLA was based on data from a clinical study assessing the pharmacokinetics of switching between adalimumab and adalimumab-bwwd for patients with moderate to severe plaque psoriasis.

Twenty states proposed bills to prohibit white bagging and brown bagging policies this year.

Both newly approved shots possess activity against subvariant EG5.1, which represents an estimated 21.5% of currently circulating variants

Researchers determined that simultaneously targeting the BRD4 and LOXL2 proteins disrupts their interaction and inhibits the growth of triple-negative breast cancer cells.

Launching development of SOPs and communication with wholesalers is key.

Women with inflammation during COVID-19 infection are at higher risk for Long Covid symptoms, according to study results.

With this approval, fruquintinib is the first and only selective inhibitor of all 3 VEGR receptor kinases to be approved in the United States for previously treated mCRC, regardless of biomarker status.

Socioeconomic, racial, and insurance disparities impact individuals' health before and after receiving surgery to treat adolescent idiopathic scoliosis.

Pharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.

Domvanalimab plus zimberelimab with chemotherapy demonstrated a positive overall response rate and 6-month progression free survival rate for patients with upper gastrointestinal cancers.

More individuals with systemic lupus erythematosus treated with anifrolumab-fnia reached remission compared to the placebo.

Perfluorohexyloctane is the first and only treatment that targets tear evaporation to provide relief for dry eye disease

Preventative drug lists were associated with a modest increase in adherence to combination inhaled corticosteroid long-acting β2-agonists.

Pharmacists should consult state boards of pharmacy and local, state, or national associations to understand how regulations apply to them

Dr. Christina Madison, speaks with Dr. Jade Ranger, from the Prescription Shoppe in this episode of Public Health matters.

Data show patients are willing to accept associated risks for a chance at a cure.